Call for Papers

Value in Health is distributing a Call for Papers to invite submissions for a special collection of papers focused on Evaluating Genomic and Precision Medicine. As genomic and precision medicine enters routine clinical care, methods for evaluating their effects on patients, families, providers, payers, and health systems are also advancing. This rapidly evolving field raises important questions about evidence generation, valuation, reimbursement, implementation, and equity.

The Editors invite conceptual, empirical, methodological, or policy-oriented submissions that evaluate genomic and precision medicine. Submissions received before March 1, 2027 will have the best chance of being published in Value in Health in 2027.

Authors should submit manuscripts through the journal's online submission system at https://mc.manuscriptcentral.com/valueinhealth. Also, be sure to indicate in your cover letter that the paper is to be considered as part of the Genomic and Precision Medicine theme.

CALL FOR PAPERS   SUBMIT NOW

Value in Health is distributing a Call for Abstracts to invite submissions for a special collection of papers focused on real-world data (RWD) for comparative effectiveness in health technology assessment (HTA). This themed section aims to capture methodological advances and novel uses of RWD for estimating treatment effects in HTA. Following ISPOR’s mission, papers must promote good research practices and transparency in the design, analysis, and reporting of RWD. The editors are most interested in papers that propose novel causal inference methods and policy-relevant applications in decision-grade RWD and target trial emulation. 

All interested authors are invited to submit an abstract for consideration in this themed section no later than November 30, 2026. Abstracts should not exceed 500 words and should be submitted to our online portal at https://vihabstracts2.secure-platform.com/a. Abstract submissions must also include a title page that includes the proposed title of the paper, names and affiliations of all authors and corresponding author, and expected word count and number of graphical elements of the final paper. The abstracts will be reviewed internally by the Guest Editors. Authors whose abstracts best fit the scope, vision, and goals of this initiative will be invited to submit full papers for consideration in this themed section.

CALL FOR PAPERS   SUBMIT NOW

Evidence synthesis—including systematic reviews with narrative, qualitative, and/or quantitative synthesis—is an important set of approaches to summarizing multiple sources of evidence, as well as identifying methods and evidence gaps in the field of health economics and outcomes research (HEOR). Evidence synthesis provides a strong foundation for the development of evidence-informed best practice recommendations and new methods and applications. Evidence synthesis and meta-analyses are also important ways of obtaining data inputs for economic models used to assess the value of health technologies.

Recognizing the inherent usefulness of evidence synthesis, the Editors of Value in Health are issuing an open Call for Papers reporting evidence synthesis on a wide array of topics in HEOR that seek to inform healthcare decision making. Papers on evidence synthesis are welcome on any topic in HEOR that lies within the aims and scope of Value in Health. Studies can address any aspect of the methods and evidence used to assess the value of healthcare, but papers reporting reviews of studies containing only clinical endpoints are out of scope for this call.

Authors should submit manuscripts through the journal's online submission system at https://mc.manuscriptcentral.com/valueinhealth. Also, be sure to indicate in your cover letter that the paper is to be considered as a systematic review.

Call for Papers   Submit Now